reliability
of technology

Our technological reliability has already been proven by several previous toxicity tests and efficacy tests.

This time, we are the first to conduct clinical trials of the PPAR γ inflammation mechanism, which was not implemented not only in Korea but also abroad, with a drug manufactured at a large-capacity production facility of GMP.

PPAR γ (Peroxisome properator-activated receptor/peroxisome proliferator-activated receptor)

PPAR γ is a nuclear hormone receptor and plays a very important role in differentiation of skin cells, recovery of barrier function, and lipid biosynthesis.
Secretions: Skin, macrophages, adipocytes, muscles, heart, liver, kidney, etc

Roles

Involved in controlling various inflammatory responses

Intracutaneous inhibitory activity of TSLP, TNF and MMP9
Inhibition of NFkB, COX-2 in macrophages: Inhibition of the secretion of cytokines such as nitric oxide (NO), TNF, IL-4, IL-5, IL-13
Effect of reducing neutrophil count and inhibiting MPO activity

Storage of fatty acids and regulating sugar metabolism, improving insulin responsiveness

Differentiation of technology

Our technological differentiation is to transform into different plant cell combinations to generate and develop new anti-inflammatory.

The biggest problem in current biological systems of other companies is safety and the transformability of bacteria.

There are risk factors such as the problem of separation in the process of cloning and applying bacteria to clone, and the environment in which bacteria are converted, but our company These challenges have been solved.

Technical application

antibacterial action
an anti-inflammatory disease
antifungal bacteria
Anti-virus
a fungal fungus
a microorganism
a pathogen

targeted therapy

Technical application

"Germs kill with germs"

Skin microbiome suppression

inhibition of mRNA expression

PPAR γ inflammation suppression

inflammatory skin disease

biofilm inhibition

LPS control for inflammatory substances